(Q73880837)

English

A multicenter phase II study of a five-day regimen of oral 5-fluorouracil plus eniluracil with or without leucovorin in patients with metastatic colorectal cancer

scientific article published on 01 April 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10847459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A multicenter phase II study of a five-day regimen of oral 5-fluorouracil plus eniluracil with or without leucovorin in patients with metastatic colorectal cancer (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10847459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

colorectal cancer

1 reference

based on heuristic

inferred from title

metastatic colon cancer

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

R L Schilsky

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10847459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

R Bukowski

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10847459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

H Burris

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10847459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

H Hochster

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10847459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M O'Rourke

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10847459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J G Wall

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10847459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

S Mani

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10847459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

T Bonny

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10847459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J Levin

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10847459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J Hohneker

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10847459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 April 2000

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10847459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Annals of Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10847459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10847459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10847459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

415-420

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10847459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008356522080

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008356522080

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacokinetics of high-dose leucovorin calcium after intravenous and oral administration

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008356522080

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind trial of fluorouracil plus placebo versus fluorouracil plus oral leucovorin in patients with metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008356522080

7 January 2021

based on heuristic

inferred from DOI database lookup

5-Ethynyluracil (776C85): a potent modulator of the pharmacokinetics and antitumor efficacy of 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008356522080

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008356522080

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I clinical and pharmacologic study of eniluracil plus fluorouracil in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008356522080

7 January 2021

based on heuristic

inferred from DOI database lookup

Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008356522080

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenase

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008356522080

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008356522080

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10847459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10847459%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73880837&oldid=1756748321"